CPT code 87150 covers amplified DNA or RNA probe analysis performed on a previously isolated and identified organism to provide more specific classification, often to the taxonomic type level. This laboratory molecular test supports clinical decision-making, infection control, epidemiology, and public health surveillance by refining organism identification beyond standard phenotypic methods. Nationally, accurate organism typing informs antimicrobial stewardship and outbreak response across acute care and reference laboratory settings. Key payers referenced in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will find benchmarks on utilization and reimbursement patterns, summaries of payer coverage considerations, and clinical context on when amplified probe organism typing is used versus other molecular or culture-based methods. The publication outlines common clinical scenarios prompting the test, typical laboratory workflows and sites of service, and policy updates affecting lab billing for molecular identification procedures. Data not available in the input is noted where applicable.